Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-09 4:04 pm Purchase | 13G | BETTER THERAPEUTICS INC BTTX | FARALLON CAPITAL MANAGEMENT LLC | 1,350,000 5.7% | 1,350,000 (New Position) | View |
| 2022-02-09 4:02 pm Purchase | 13G | SEP ACQUISITION CORP SEPA | FARALLON CAPITAL MANAGEMENT LLC | 1,732,500 9.6% | 1,732,500 (New Position) | View |
| 2022-02-09 4:00 pm Purchase | 13G | SHELTER ACQUISITION CORP I CL SHQA | FARALLON CAPITAL MANAGEMENT LLC | 1,650,000 7.4% | 1,650,000 (New Position) | View |
| 2022-02-09 3:58 pm Purchase | 13G | INFLECTION PT ACQUISITION CORP IPAX | FARALLON CAPITAL MANAGEMENT LLC | 1,900,000 5.8% | 1,900,000 (New Position) | View |
| 2022-02-08 12:05 pm Purchase | 13G | SDCL EDGE ACQUISITION CORP SEDA | FARALLON CAPITAL MANAGEMENT LLC | 1,732,500 8.7% | 1,732,500 (New Position) | View |
| 2022-02-08 12:03 pm Purchase | 13G | SAVARA INC SVRA | FARALLON CAPITAL MANAGEMENT LLC | 11,775,632 9.99% | 6,260,745 (+113.52%) | View |
| 2022-02-08 12:00 pm Sale | 13G | PROGENICS PHARMACEUTICALS INC PGNX | FARALLON CAPITAL MANAGEMENT LLC | 0 0% | -8,500,000 (Position Closed) | View |
| 2022-02-08 11:57 am Unchanged | 13G | NEXTDOOR HOLDINGS, INC. KIND | FARALLON CAPITAL MANAGEMENT LLC | 0 0% | 0 (Unchanged) | View |
| 2022-02-08 11:54 am Purchase | 13G | MARBLEGATE ACQ.CORP GATE | FARALLON CAPITAL MANAGEMENT LLC | 2,970,000 9.6% | 2,970,000 (New Position) | View |
| 2022-02-08 11:52 am Unchanged | 13G | BIOATLA INC BCAB | FARALLON CAPITAL MANAGEMENT LLC | 0 0% | 0 (Unchanged) | View |
| 2022-02-08 11:48 am Purchase | 13G | ARAMARK ARMK | FARALLON CAPITAL MANAGEMENT LLC | 17,962,483 7% | 17,962,483 (New Position) | View |
| 2022-02-03 09:28 am Purchase | 13G | DISRUPTIVE ACQUISITION CORP I DISA | FARALLON CAPITAL MANAGEMENT LLC | 1,400,000 5.1% | 1,400,000 (New Position) | View |
| 2022-02-03 09:23 am Purchase | 13G | GENERATION BIO CO GBIO | FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 6.2% | 229,500 (+7.02%) | View |
| 2022-02-03 09:22 am Purchase | 13G | IMAGO BIOSCIENCES INC IMGO | FARALLON CAPITAL MANAGEMENT LLC | 2,471,313 7.4% | 2,471,313 (New Position) | View |
| 2022-02-03 09:18 am Sale | 13G | TRINITY MERGER CORP UNIT 1 CL TMCXU | FARALLON CAPITAL MANAGEMENT LLC | 6,643,653 4.9% | -2,320,213 (-25.88%) | View |
| 2022-02-03 09:10 am Unchanged | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | FARALLON CAPITAL MANAGEMENT LLC | 810,500 6% | 0 (Unchanged) | View |
| 2022-01-27 12:17 pm Purchase | 13G | BIG SKY GROWTH PARTNERS INC BSKYW | FARALLON CAPITAL MANAGEMENT LLC | 1,550,000 5.2% | 1,550,000 (New Position) | View |
| 2022-01-27 12:13 pm Purchase | 13G | ARYA SCIENCES ACQUISITION CORP ARYD | FARALLON CAPITAL MANAGEMENT LLC | 800,000 5.2% | 800,000 (New Position) | View |
| 2022-01-27 12:08 pm Purchase | 13G | BERENSON ACQUISITION CORP I CL BACA | FARALLON CAPITAL MANAGEMENT LLC | 2,662,500 9.6% | 2,662,500 (New Position) | View |
| 2021-12-23 6:39 pm Purchase | 13G | SWIFTMERGE ACQ.CORP UNIT 1 CL IVCPU | FARALLON CAPITAL MANAGEMENT LLC | 1,980,000 9.9% | 1,980,000 (New Position) | View |